BLADDER CANCER;
CANCER CELL;
CANCER CHEMOTHERAPY;
CANCER IMMUNOTHERAPY;
CANCER INVASION;
CANCER MORTALITY;
CANCER RECURRENCE;
CANCER STAGING;
CARCINOMA IN SITU;
CLINICAL TRIAL;
CYSTECTOMY;
HUMAN;
LAMINA PROPRIA;
MORBIDITY;
PRIORITY JOURNAL;
QUALITY OF LIFE;
REVIEW;
RISK FACTOR;
RISK REDUCTION;
SURGICAL TECHNIQUE;
TRANSURETHRAL RESECTION;
URINARY DIVERSION;
The 3-month clinical response to intravesical therapy as a predictive factor for progression in patients with high risk superficial bladder cancer
Solsona E et al. (2000) The 3-month clinical response to intravesical therapy as a predictive factor for progression in patients with high risk superficial bladder cancer. J Urol 164: 685-689
Second resection and prognosis of primary high risk superficial bladder cancer: Is cystectomy often too early?
Brauers A et al. (2001) Second resection and prognosis of primary high risk superficial bladder cancer: is cystectomy often too early? J Urol 165: 808-810